ISPC Stock Summary and Trading Ideas (Ispecimen | NASDAQ:ISPC)

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Ispecimen trades on the NASDAQ stock market under the symbol ISPC.

As of April 17, 2025, ISPC stock price declined to $1.24 with 31,750 million shares trading.

ISPC has a beta of 0.38, meaning it tends to be less sensitive to market movements. ISPC has a correlation of 0.00 to the broad based SPY ETF.

ISPC has a market cap of $1.19 million. This is considered a Sub-Micro Cap stock.

Last quarter Ispecimen reported $1 million in Revenue and -$6.28 earnings per share. This fell short of revenue expectation by $-42 million and missed earnings estimates by -$6.21.

In the last 3 years, ISPC traded as high as $89.60 and as low as $1.02.

The top ETF exchange traded funds that ISPC belongs to (by Net Assets): VXF.

ISPC has underperformed the market in the last year with a return of -70.9%, while the SPY ETF gained +6.0%. In the last 3 month period, ISPC fell short of the market, returning -56.7%, while SPY returned -10.7%. However, in the most recent 2 weeks ISPC has outperformed the stock market by returning -2.8%, while SPY returned -6.8%.

ISPC support price is $1.19 and resistance is $1.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ISPC shares will trade within this expected range on the day.